Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alisa Taliansky"'
Autor:
R Shapira-Frumer, Moran Gadot, O Furman, N Asher, Alisa Taliansky, Bella Kaufman, Raya Leibowitz-Amit, A Itay, Damien Urban, Jair Bar
Publikováno v:
Supportive Care in Cancer
Background Treatment with immune checkpoint inhibitors (ICI) has greatly improved survival for patients with a number of malignant diseases in recent years. Neurological immune-related adverse events (n-irAE) of varying severity have been reported in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6bf068717c03ee3f568281f442d869
https://doi.org/10.1007/s00520-021-06331-5
https://doi.org/10.1007/s00520-021-06331-5
Autor:
Shaye Kivity, Alisa Taliansky, Lior Seluk, Yehuda Shoenfeld, Boris Gilburd, Hagith Yonath, Howard Amital
Publikováno v:
Clinical Immunology. 199:29-36
Background Paraneoplastic neurological syndromes (PNS) are a group of syndromes that affect the central and peripheral neuromuscular system in association with cancer. Specific antibodies may assist in the diagnosis of PNS. The antibodies tested can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c613359b8660991f9f43aa8d76d23508
https://doi.org/10.1016/j.clim.2018.12.007
https://doi.org/10.1016/j.clim.2018.12.007
Autor:
Michal Lotem, Shai Rosenberg, Elena Kogan, Suzana Fichman, Shlomit Yust-Katz, Alexander Lossos, Avi Fellner, Israel Steiner, Alisa Taliansky, Chen Makranz, Deborah T. Blumenthal, Jacob Mandel, Felix Bokstein, Tali Siegal
Publikováno v:
Journal of Neuro-Oncology. 137:601-609
Immune checkpoint inhibitors (ICPIs) have recently emerged as a novel treatment for cancer. These agents, transforming the field of oncology, are not devoid of toxicity and cause immune-related side effects which can involve any organ including the n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd6b5bc43d29f19ed3096e626aba4360
https://doi.org/10.1007/s11060-018-2752-5
https://doi.org/10.1007/s11060-018-2752-5
Autor:
Alisa Taliansky, Teodor Gottfried, Elizabeth Dudnik, Raya Leibowitz-Amit, Raanan Berger, Katerina Shulman, Damien Urban, Talia Golan, Jair Bar, Amir Onn, Gal Markel, Sameh Daher, Ruth Percik
Publikováno v:
European journal of cancer (Oxford, England : 1990). 120
Aim Immune-related toxicities of immune checkpoint inhibitors (CPIs) require prompt diagnosis and treatment. Atherosclerosis has an inflammatory component; we speculated this inflammation could be enhanced by CPIs. We aimed to evaluate the risk of ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd4b3737a665cb52a4e261b3fbf3d13
https://pubmed.ncbi.nlm.nih.gov/31518968
https://pubmed.ncbi.nlm.nih.gov/31518968
Autor:
Oleg Merzlyak, C Granbichler, Yvonne Schwammenthal, David Orion, Rakefet Tsabari, Stefan Mausbach, Joab Chapman, Alisa Taliansky, Mati Bakon
Publikováno v:
Neuro-Oncology. 20:iii319-iii320
BACKGROUND: Thromboembolism is the second leading cause of death in cancer. Stroke is one of thrombotic events that can dramatically change the patient functional status and influence the modality and intensity of oncological treatment. There are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3a263ff653f9ba4578a5c51940d432
https://doi.org/10.1093/neuonc/noy139.397
https://doi.org/10.1093/neuonc/noy139.397
Autor:
David Guez, Leor Zach, Dianne Daniels, Shirley Sharabi, Ouzi Nissim, Roberto Spiegelmann, Arielle Tylim, Alisa Taliansky, Yigal Shoshan, Deborah Blumenthal, Felix Bokstein, Zvi Cohen, Yael Mardor, David Last
Publikováno v:
Neuro-Oncology. 20:vi183-vi183
INTRODUCTION: TRAMs calculated from delayed-contrast MRI enable reliable (sensitivity/specificity>70%) differentiation between tumor (blue in the TRAMs) and non-tumoral tissues (red). The TRAMs are calculated by subtracting 3D T1-MRIs acquired 5min (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::174fb619ccb508ed5e5d28d30ce3decd
https://doi.org/10.1093/neuonc/noy148.761
https://doi.org/10.1093/neuonc/noy148.761
Autor:
Deborah T. Blumenthal, Leor Zach, Zvi Ram, Alisa Taliansky, Rachel Grossman, Alexander Lossos, Anca Leibovici, Shlomit Yust-Katz, Felix Bokstein, Alejandro Lokiec, Tali Siegal, Tzahala Tzuk-Shina, Itay Forschner
Publikováno v:
Neuro-Oncology. 20:vi119-vi119
BACKGROUND: TTFields are low intensity, intermediate frequency alternating electric fields, delivered through a portable, non-invasive device (Optune, Novocure(TM)). The EF-14 phase III trial showed significant prolongation of both progression-free a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a4f27d7f280b8781c0becb19159460
https://doi.org/10.1093/neuonc/noy148.496
https://doi.org/10.1093/neuonc/noy148.496
Autor:
Alisa Taliansky, Anat Mordechai, Lior Zach, Alexander Lossos, Deborah T. Blumenthal, Bracha Zelikovitsh, Tzahallah Tzuk-Shina, Iris Lavon, Felix Bokstein
Publikováno v:
Neuro-Oncology. 16:v96-v97
BACKGROUND: Concurrent radiation (RT) and temozolomide (TMZ) has been accepted as standard first-line therapy for glioblastoma since publication of results of the phase III EORTC/NCIC trial in 2005. In the same NEJM issue, data were presented which s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff293ec9349d6859ac3ef9ead053efa
https://doi.org/10.1093/neuonc/nou256.4
https://doi.org/10.1093/neuonc/nou256.4